Jpmorgan Chase & CO SAREPTA THERAPEUTICS INC Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025
Number of Shares
3,803,000
Previous 6,612,000 42.48%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
N/A
-2,809,000 Reduced 42.48%
3,803,000 $0
Q4 2024

Feb 12, 2025
BUY
N/A
784,000 Added 13.45%
6,612,000 $0
Q3 2024

Dec 26, 2024
BUY
N/A
1,624,000 Added 38.63%
5,828,000 $0
Q3 2024

Nov 08, 2024
BUY
N/A
1,624,000 Added 38.63%
5,828,000 $0
Q2 2024

Dec 26, 2024
SELL
N/A
-1,624,000 Reduced 27.87%
4,204,000 $0
Q2 2024

Aug 12, 2024
SELL
N/A
-1,246,000 Reduced 22.86%
4,204,000 $0
Q1 2024

Dec 26, 2024
SELL
N/A
-378,000 Reduced 6.49%
5,450,000 $0
Q1 2024

May 10, 2024
BUY
N/A
2,941,000 Added 117.22%
5,450,000 $0
Q4 2023

Dec 26, 2024
SELL
N/A
-3,319,000 Reduced 56.95%
2,509,000 $0
Q4 2023

Feb 12, 2024
SELL
N/A
-1,311,000 Reduced 34.32%
2,509,000 $0
Q3 2023

Nov 14, 2023
BUY
N/A
3,820,000 New
3,820,000 $0
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email